A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 80
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SCS
Long Form : subclinical Cushing's syndrome
No. Year Title Co-occurring Abbreviation
2020 A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders. CORT, CVs, DHT, LLOQ, PCOS
2020 Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome. CT, DM, MTD, PA
2020 Three-year follow up of adrenal incidentalomas in a New Zealand centre. AI
2019 Diagnostic value of the late-night salivary cortisol in the diagnosis of clinical and subclinical Cushing's syndrome: results of a single-center 7-year experience. CCS, LNSaC
2019 Is Prophylactic Steroid Treatment Mandatory for Subclinical Cushing Syndrome After Unilateral Laparoscopic Adrenalectomy? AI
2019 Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas. ---
2019 When to Intervene for Subclinical Cushing's Syndrome. ---
2018 Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI). BMI, IL-6, MCP-1, NFAI, TNF-alpha
2018 Adrenalectomy was recommended for patients with subclinical Cushing's syndrome due to adrenal incidentaloma. AI
10  2018 Expression of adiponectin and leptin receptors in adrenal incidentaloma patients with subclinical hormone secretion. BMI, PHEO
11  2018 New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society. ACTH, CRH, DST
12  2017 A Novel Method: Super-selective Adrenal Venous Sampling. APA, cAVS, PA, PACs, PCCs, ssAVS, TVs
13  2017 Adrenal Incidentaloma and Subclinical Cushing's Syndrome: A Longitudinal Follow-Up Study by Endoscopic Ultrasound. EUS, NFA, NFM
14  2017 Baseline Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in China: A Survey. AI
15  2017 Six controversial issues on subclinical Cushing's syndrome. ---
16  2017 Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome? CS, DST, T2DM
17  2017 [Clinical value of tumor size in the evaluation of adrenal incidentalomas]. AI, PA
18  2017 [Diagnostic value of urinary free cortisol in the subclinical Cushing's syndrome in patients with adrenal incidentaloma]. 24hUFC, CS, NFA, UFCCR
19  2017 [Surgery versus conservative management for subclinical Cushing's syndrome in adrenal incidentalomas]. AI
20  2016 Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas. ACS, DST
21  2016 Serum Adiponectin Level as a Predictor of Subclinical Cushing's Syndrome in Patients with Adrenal Incidentaloma. AI, NAI
22  2016 Subclinical Cushing's syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis. BAI, CIs, MD, RD, UAI
23  2016 THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis. NF
24  2015 Activity of selected coagulation factors in overt and subclinical hypercortisolism. OCS, vW, vWF
25  2015 Assessment of platelet function in endogenous hypercortisolism. AS, CT, EPI, OCS, SC
27  2015 DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous? DHEAS
28  2015 Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome? CS, LDDST, T2DM
29  2015 Systematic review of surgical treatment of subclinical Cushing's syndrome. ---
30  2015 The clinical course of patients with adrenal incidentaloma: is it time to reconsider the current recommendations? ---
31  2015 [Clinical Evaluation of Primary Aldosteronism with Subclinical Cushing's Syndrome]. ACTH, PA
32  2015 [Evaluation of the 1 mg overnight dexamethasone suppression test in the diagnosis of the subclinical Cushing's syndrome in patients with Adrenal Incidentaloma]. NFA
33  2014 Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. BAI, UAI
34  2014 Clinical Characteristics and Metabolic Features of Patients with Adrenal Incidentalomas with or without Subclinical Cushing's Syndrome. CT
35  2014 Long-term study of subclinical Cushing's syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors. ---
36  2014 Nonconformity in the clinical practice guidelines for subclinical Cushing's syndrome: which guidelines are trustworthy? AGREE-II, CPGs, IACE, IOM
37  2014 Subclinical Cushing syndrome: a review. ---
38  2014 The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's syndrome and the prediction of post-surgical hypoadrenalism. ACS, BP, PH
39  2013 A case of incidentally discovered subclinical cushing syndrome in a patient with chronic fatigue and anxiety. ---
40  2013 Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing's syndrome. ALP, CS, DST, NF, NS
41  2013 Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism. ACTH, APA
42  2013 Challenges in the diagnostic work-up and management of patients with subclinical Cushing's syndrome and bilateral adrenal masses. ACTH, AVS, BP, CT, MRI
43  2013 Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. CI, OR
44  2013 Diagnostics of hypercortisolism - comparison between the clinical usefulness of salivary and serum cortisol measurements. AUC, LSC, OCS, PCS, ROC, UFC
45  2013 Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications. AI, BMI, HC, HOMA, IS, NAI, OGTT, QUICKI, TyG
46  2013 Primary aldosteronism associated with subclinical Cushing syndrome. CS, PA
47  2013 Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma. CS, DST, EIA, RIA
48  2013 Significantly high level of late-night free cortisol to creatinine ratio in urine specimen in patients with subclinical Cushing's syndrome. 1mg-DST, NF, UFC
49  2013 Subclinical Cushing's syndrome in adrenal incidentalomas--possible metabolic consequences. NA
50  2012 Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. BP
51  2012 Clinical outcomes of surgical treatment and longitudinal non-surgical observation of patients with subclinical Cushing's syndrome and nonfunctioning adrenocortical adenoma. DM, HL, HT, NFA
52  2012 Clinical Usefulness of Corticotropin Releasing Hormone Testing in Subclinical Cushing's Syndrome for Predicting Cortisol Replacement after Adrenalectomy. CRH
53  2012 Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing's syndrome. CS, DST, NFA, NSC, PA, PHEO, SC
54  2012 Glucose metabolism in patients with subclinical Cushing's syndrome. AI
55  2012 Homocysteine and alpha-1 antitrypsin concentration in patients with subclinical hypercortisolemia. alpha1ATp, Hcy
56  2012 Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas. CVD, MS, T2DM
57  2012 Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. CHD, CI, DST, NSA, OR, T2D
58  2012 Subclinical Cushing's syndrome. ---
59  2012 Subclinical Cushing's syndrome. HPA
60  2011 AME position statement on adrenal incidentaloma. CT, HU, PET
61  2011 Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment. DM, IGT, OP
62  2011 Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism. AI, MS
63  2011 Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome. PA, PA/SCS
64  2011 Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma. ACC, DHEA, IGF
65  2011 Increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas. CPA, NA, NFA, PCR
66  2011 The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing's syndrome. APCR, AT, FPS, PC, TM
67  2010 Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. UFC
68  2010 Incidental and metastatic adrenal masses. AIs, FNB
69  2010 Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. NF
70  2010 Posterior retroperitoneoscopic adrenalectomy for clinical and subclinical Cushing's syndrome. mCS, POSS
71  2010 Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas. CT, MRI
72  2010 Screening for subclinical Cushing's syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol. DST, NSC
73  2009 Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. DM
74  2009 Unrecognized adrenal insufficiency in patients undergoing laparoscopic adrenalectomy. AI, ANOVA, POD1
75  2009 Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome. BMD
76  2008 Subclinical Cushing's syndrome is a potential cause of metabolic dementia and rapidly progressive Alzheimer-type dementia. ---
77  2006 Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. CS
78  2003 Occult Cushing's syndrome in type-2 diabetes. DST
79  2003 Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. DXM, NFA
80  2002 Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. ---